Skip to content.
About GPO   |   Newsroom/Media   |   Congressional Relations   |   Inspector General   |   Careers   |   Contact   |   askGPO   |   Help  
 

  FDsys > More Information
(Search string is required)
 

16-17753 - Donald v. AstraZeneca Pharmaceuticals LP et al


Download Files

Metadata

Document in Context
16-17753 - Donald v. AstraZeneca Pharmaceuticals LP et al
March 22, 2017
PDF | More
ORDERED that the 8 Motion to Dismiss for Failure to State a Claim is granted in part and denied in part. ORDERED that only the plaintiff's claims for defect in design, defect in composition or construction, and failure to warn under the LPLA survive this motion to dismiss. FURTHER ORDERED that all non-LPLA claims are dismissed with prejudice. FURTHER ORDERED that the plaintiff's claim for breach of express warranty under the LPLA is dismissed. Signed by Judge Martin L.C. Feldman on 3/22/2017. (clc)